Cipla Limited - CSR Impact Assessment Report
CSR Impact Assessment Report
Cipla Limited
Report
May 2023
Cipla Limited - CSR Impact Assessment Report | |
Table of Contents | |
Overview of CSR Implementation Strategy and Cipla Foundation | |
Research Framework | 6 |
Results of CSR Impact Assessment | 7 |
Palliation Projects | 7 |
Respiratory Care Support Programme | 16 |
Patient Support and Medical Assistance | 24 |
Strengthening Health Systems | 28 |
Community Health / Doorstep Health | 31 |
COVID-19 Response | 42 |
Promoting Quality Education | 48 |
E-Learning | 55 |
Vocational Training | 58 |
Research | 62 |
Scholarships | 63 |
Others - Disaster Relief | 65 |
Conclusion | 67 |
Cipla Limited - CSR Impact Assessment Report
Executive Summary
With a prime purpose of 'Caring for Life', Cipla Limited through its's philanthropy arm, i.e., Cipla Foundation (Foundation) continues its passionate journey of social change with the power of collaborations with various implementation agencies. All the CSR Activities of Cipla Limited are undertaken by the Company either directly or through the Foundation. The Foundation collaborates with various credible institutions, NGOs, government agencies and domain experts to enhance the outreach of its CSR initiatives. Helpage India, Council of Scientific and Industrial Research - Indian Institute of Chemical Technology (CSIR - IICT), Ambuja Cement Foundation, Sankalp, Institute of Liver and Biliary Sciences (ILBS) are a few implementation partners with whom Cipla Foundation has collaborated across various geographies covering, Maharashtra, Baddi, New Delhi, Bangalore, to name a few.
As mandated by the statutory provisions, Cipla Foundation is obligated to assess the impact of its CSR projects that were completed over a year ago. For the purpose of the impact study, OECD DAC Evaluation Criteria was used for assessing the impact. The framework has defined six (6) evaluation criteria, i.e., Relevance, Coherence, Effectiveness, Efficiency, Impact, and Sustainability. The projects considered for the study are highlighted below1:
S.No. | CSR Initiative | Key Impact | SDG Mapping | |||||
• | 15,000+ beneficiaries availing institutional care | |||||||
• | More than 15,000 calls received on Saath-Saath helpline | SDG 3 - Good Health | ||||||
1 | Palliation Projects | • | 1,600+ healthcare professionals were trained across 15 | |||||
and Well- Being | ||||||||
• | hospitals and medical colleges | |||||||
Collaborations with 28 partners in 21 cities across India | ||||||||
2 | Respiratory Care Support | • | 500 days of hospitalisation was avoided due to PRC | SDG 3 - Good Health | ||||
Programme | • | 335 post-COVID patients enrolled in PRC program | and Well- Being | |||||
3 | Patient support/ medical | • | 312 children were supported for thalassemia management and | SDG 3 - Good Health | ||||
assistance | chemotherapy support | and Well- Being | ||||||
4 | Strengthening health | • | More than 7,000 beneficiaries were benefitted | SDG 3 - Good Health | ||||
systems | and Well- Being | |||||||
• | SDG 3 - Good Health | |||||||
5 | Community health/ | 1,516 healthcare professional trained on management of viral | and Well- Being | |||||
Doorstep health | hepatitis | |||||||
• | More than 1,15,000 free-of-costRT-PCRCOVID-19 tests were | |||||||
supported for patients with financial difficulties across | ||||||||
6 | COVID-19 response | • | Maharashtra | SDG 3 - Good Health | ||||
50,000+ Rapid Antigen Kits were provided | and Well- Being | |||||||
• | 11,000+ facemasks/PPE kits/disposal gowns and gloves were | |||||||
provided | ||||||||
7 | Promoting Quality | • | 2,500+ students benefitted from school infrastructure | SDG 4 - Quality | ||||
Education | Education | |||||||
8 | E-learning | • | 5,573 tablets were distributed with pre-loaded content | SDG 4 - Quality | ||||
Education | ||||||||
9 | Vocational training | • | 100+ Self-Help Group beneficiaries were trained online for | SDG 4 - Quality | ||||
Project 'SAANS' | Education | |||||||
10 | Research | • | 1,050 beneficiaries/individuals, contributing to nearly 480 | SDG 4 - Quality | ||||
person hours via outreach webinars and lectures | Education | |||||||
SDG 4 - Quality | ||||||||
11 | Scholarship | • | 282 students were awarded merit awards | Education | ||||
SDG 5 - Gender | ||||||||
Equality | ||||||||
• | Nearly 795 people from 167 families came regularly to the | SDG 13 - Climate Action | ||||||
12 | Others - Disaster Relief | SDG 17 - Partnerships | ||||||
community kitchen for meals for a period of one month | ||||||||
for the goals |
Overview of Cipla Limited
>
Cipla Limited - CSR Impact Assessment Report
Cipla Limited is a global pharmaceutical company, established in 1935, focused on sustainable growth with a firm commitment to make medicines available and accessible to all. It's product portfolio includes complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, Central Nervous System (CNS), and various other key therapeutic segments. The Company has 47 manufacturing sites across the globe, producing 50+ dosage forms and 1,500+ products using cutting-edge technology platforms catering to nearly 86 markets.
Overview of CSR Implementation Strategy and Cipla Foundation
With an intent to contribute to the society, and empower vulnerable communities, Cipla envision for an equitable world built on the foundation of 'Caring for Life'. The Company recognises the importance of building long-term relationships with all its stakeholders, thereby, working together to achieve societal change and creating an impact.
Cipla's work in the community is pre-dominantly carried out through its philanthropy arm, i.e., Cipla Foundation, its Principal Implementation Agency for all the CSR activities of the Company and its subsidiaries. All CSR Activities of Cipla Limited are undertaken by the Company either directly and through Cipla Foundation. The Foundation works with credible institutions, NGOs, government agencies and domain experts to enhance the outreach of its CSR initiatives. Helpage India, Council of Scientific and Industrial Research - Indian Institute of Chemical Technology (CSIR - IICT), Ambuja Cement Foundation, Sankalp, Institute of Liver and Biliary Sciences (ILBS) are a few implementation partners with whom Cipla Foundation has collaborated across various geographies covering, Maharashtra, Baddi, New Delhi, Bangalore, to name a few.
CSR Policy and Key Thrust Areas
'Caring for Life' has been at the forefront of Cipla's business philosophy and remains the principal purpose of doing business. This philosophy is seamlessly integrated into Cipla's people, products and processes and is the foundation and underlying objective, of the Corporate Social Responsibility Policy of Cipla Limited. Cipla Limited has formulated a CSR Policy in accordance with the provisions of section 135(4)(a) of the Company's Act and CSR Rules, which is amended from time to time.
The key thrust areas that are outlined in the CSR Policy of the Company are as follows:
Cipla Limited - CSR Impact Assessment Report
Weblink to the CSR Policy -https://www.cipla.com/sites/default/files/2021-03/Corporate-Social-Responsibility-Policy.pdf
CSR Governance Mechanism
The Foundation maintains the highest standards of ethics, compliance and due diligence, with robust auditing and monitoring mechanisms to govern its engagements with various implementation partners and stakeholders. The Company's CSR governance mechanism is the backbone of all its CSR implementation activities as highlighted below.
Charter of CSR Committee - https://www.cipla.com/sites/default/files/2022-04/Charter-of-the-corporate-social-responsibility-committee.pdf
Approach and Methodology
Rationale of the study
To undertake social impact assessment of CSR initiatives being implemented by Cipla Foundation for FY 2020-21 across various key thrust areas and FY 2021-22 for Covid-19 response, in accordance with CSR Rules, wherein, minimum one year has elapsed since implementation of the projects.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Cipla Ltd. published this content on 19 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 July 2023 16:42:01 UTC.